[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.55.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 2, 2003

Pain Management in Patients With Osteoarthritis—Reply

Author Affiliations
  • 1Department of Orthopaedics, Pennsylvania Hospital, Philadelphia
JAMA. 2003;290(1):36. doi:10.1001/jama.290.1.36-c

In Reply: Dr Finucane points out that the safety profiles of celecoxib and standard NSAIDs are roughly comparable at 12 months. It is unclear why gastric ulcerative changes would differ at 6 or 12 months or whether the same can be said for rofcoxib, another COX-2 inhibitor.1 Nonetheless, physicians should consider the drugs' equivalent therapeutic benefits and cost differentials when chosing a specific NSAID for individual patients.

×